TickerFiles

Apyx Medical Corp 10-Q filing

Filed 2025-08-07 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001437749-25-025422
Form type
10-Q
CIK
0000719135
Primary document
https://www.sec.gov/Archives/edgar/data/719135/000143774925025422/apyx20250630_10q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Apyx Medical Corp.

Reported financial metrics

MetricCurrentPriorChange
Revenue$20.8M--
Cost Of Revenue$8.1M--
Gross Profit$12.7M--
Operating Income$-5.6M--
Net Income$-7.9M--
Eps Basic-0.19--
Cash And Equivalents$29.3M--
Total Assets$58.2M--
Total Liabilities$50.7M--
Shareholders Equity$7.3M--
Operating Cash Flow$-1.9M--
Capital Expenditures$320,000--